Megestrol acetate for anorexia and cachexia. 1992

C L Loprinzi, and P A Johnson, and M Jensen
Mayo Clinic, Departments of Oncology, Rochester, MN 55905.

Based on promising preliminary information obtained from uncontrolled pilot studies, several randomized, placebo-controlled, double-blind clinical trials have been launched to evaluate the effectiveness of megestrol acetate for the treatment of patients with anorexia and/or cachexia. The results of these studies have demonstrated that megestrol acetate can improve patients' appetites and promote nonfluid weight gain in some. They also suggest that megestrol acetate has antiemetic properties. Ongoing clinical trials are evaluating the dose-response relationship of megestrol acetate for these clinical problems and whether megestrol acetate will improve the survival of patients at risk for developing cancer anorexia/cachexia.

UI MeSH Term Description Entries
D008535 Megestrol A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione,Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002100 Cachexia General ill health, malnutrition, and weight loss, usually associated with chronic disease.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000855 Anorexia The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA. Anorexias
D019290 Megestrol Acetate Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) Apo-Megestrol,Borea,Lin-Megestrol,Maygace,Megace,Megefren,Megestat,Megostat,Mestrel,Nu-Megestrol,Acetate, Megestrol,Apo Megestrol,ApoMegestrol,Lin Megestrol,LinMegestrol,Nu Megestrol,NuMegestrol

Related Publications

C L Loprinzi, and P A Johnson, and M Jensen
January 2006, Journal of the American Geriatrics Society,
C L Loprinzi, and P A Johnson, and M Jensen
January 2006, International journal of nanomedicine,
C L Loprinzi, and P A Johnson, and M Jensen
June 2006, Journal of palliative medicine,
C L Loprinzi, and P A Johnson, and M Jensen
March 2013, The Cochrane database of systematic reviews,
C L Loprinzi, and P A Johnson, and M Jensen
April 2005, The Cochrane database of systematic reviews,
C L Loprinzi, and P A Johnson, and M Jensen
June 2018, Journal of cachexia, sarcopenia and muscle,
C L Loprinzi, and P A Johnson, and M Jensen
October 1994, Oncology,
C L Loprinzi, and P A Johnson, and M Jensen
April 1998, Seminars in oncology,
C L Loprinzi, and P A Johnson, and M Jensen
December 1990, Seminars in oncology,
C L Loprinzi, and P A Johnson, and M Jensen
February 1991, Seminars in oncology,
Copied contents to your clipboard!